Citations (176)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
C. Elizabeth Caldon, C. Marcelo Sergio, Andrew Burgess, Andrew J. Deans, Robert L. Sutherland & Elizabeth A. Musgrove. (2013) Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1. Cell Cycle 12:4, pages 606-617.
Read now
Read now
C. Elizabeth Caldon, C. Marcelo Sergio, Robert L. Sutherland & Elizabeth A. Musgrove. (2013) Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells. Cell Cycle 12:4, pages 596-605.
Read now
Read now
Nagesha
Guthalu Kondegowda, Mary
Pat Meaney, Chandra Baker & YoungH. Ju. (2011) Effects of Non-Digestible Carbohydrates on the Growth of Estrogen-Dependent Human Breast Cancer (MCF-7) Tumors Implanted in Ovariectomized Athymic Mice. Nutrition and Cancer 63:1, pages 55-64.
Read now
Read now
C. Elizabeth Caldon, C. Marcelo Sergio, Judith Schütte, Marijke N. Boersma, Robert L. Sutherland, Jason S. Carroll & Elizabeth A. Musgrove. (2009) Estrogen Regulation of Cyclin E2 Requires Cyclin D1 but Not c-Myc. Molecular and Cellular Biology 29:17, pages 4623-4639.
Read now
Read now
Theresa J. Peterson, Sudipan Karmakar, Margaret C. Pace, Tong Gao & Carolyn L. Smith. (2007) The Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor (SMRT) Corepressor Is Required for Full Estrogen Receptor α Transcriptional Activity. Molecular and Cellular Biology 27:17, pages 5933-5948.
Read now
Read now
Gabriella Castoria, Antimo Migliaccio, Marina Di Domenico, Maria Lombardi, Antonietta de Falco, Lilian Varricchio, Antonio Bilancio, Maria Vittoria Barone & Ferdinando Auricchio. (2004) Role of Atypical Protein Kinase C in Estradiol-Triggered G1/S Progression of MCF-7 Cells. Molecular and Cellular Biology 24:17, pages 7643-7653.
Read now
Read now
Luigi Cicatiello, Raffaele Addeo, Annarita Sasso, Lucia Altucci, Valeria Belsito Petrizzi, Raphaelle Borgo, Massimo Cancemi, Simona Caporali, Silvana Caristi, Claudio Scafoglio, Diana Teti, Francesco Bresciani, Bruno Perillo & Alessandro Weisz. (2004) Estrogens and Progesterone Promote Persistent CCND1 Gene Activation during G1 by Inducing Transcriptional Derepression via c-Jun/c-Fos/Estrogen Receptor (Progesterone Receptor) Complex Assembly to a Distal Regulatory Element and Recruitment of Cyclin D1 to Its Own Gene Promoter. Molecular and Cellular Biology 24:16, pages 7260-7274.
Read now
Read now
Zhi-Qing Ma, Zheng Liu, Elly S. W. Ngan & Sophia Y. Tsai. (2001) Cdc25B Functions as a Novel Coactivator for the Steroid Receptors. Molecular and Cellular Biology 21:23, pages 8056-8067.
Read now
Read now
James S. Foster, Donald C. Henley, Antonin Bukovsky, Prem Seth & Jay Wimalasena. (2001) Multifaceted Regulation of Cell Cycle Progression by Estrogen: Regulation of Cdk Inhibitors and Cdc25A Independent of Cyclin D1-Cdk4 Function. Molecular and Cellular Biology 21:3, pages 794-810.
Read now
Read now
Justin Lamb, Mohamed H. Ladha, Christine McMahon, Robert L. Sutherland & Mark E. Ewen. (2000) Regulation of the Functional Interaction between Cyclin D1 and the Estrogen Receptor. Molecular and Cellular Biology 20:23, pages 8667-8675.
Read now
Read now
Articles from other publishers (166)
Wei He, Diane M. Demas, Ayesha N. Shajahan-Haq & William T. Baumann. (2023) Modeling breast cancer proliferation, drug synergies, and alternating therapies. iScience 26:5, pages 106714.
Crossref
Crossref
Markus Kaller, Wenjing Shi & Heiko Hermeking. (2023) c-MYC-Induced AP4 Attenuates DREAM-Mediated Repression by p53. Cancers 15:4, pages 1162.
Crossref
Crossref
Lewei Zheng, Qian Yang, Chengxin Li, Gaoran Xu, Qianqian Yuan, Jinxuan Hou & Gaosong Wu. (2023) Ubiquitin-Specific Peptidase 8 Modulates Cell Proliferation and Induces Cell Cycle Arrest and Apoptosis in Breast Cancer by Stabilizing Estrogen Receptor Alpha. Journal of Oncology 2023, pages 1-16.
Crossref
Crossref
Wei He, Ayesha N. Shajahan-Haq & William T. Baumann. 2023. Computational Modeling of Signaling Networks. Computational Modeling of Signaling Networks
337
355
.
Xu Zhang, Yang Yang, Danyang Li, Zhen Wu, Haoyu Liu, Ziyan Zhao, Hongying Zhu, Fei Xie & Xiangzhi Li. (2022) MOF negatively regulates estrogen receptor α signaling via CUL4B-mediated protein degradation in breast cancer. Frontiers in Oncology 12.
Crossref
Crossref
Chung-Liang Li, Sin-Hua Moi, Huei-Shan Lin, Ming-Feng Hou, Fang-Ming Chen, Shen-Liang Shih, Jung-Yu Kan, Chieh-Ni Kao, Yi-Chia Wu, Li-Chun Kao, Ying-Hsuan Chen, Yi-Chen Lee & Chih-Po Chiang. (2022) Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer. International Journal of Molecular Sciences 23:18, pages 10539.
Crossref
Crossref
Nazia Rehman, Shahrukh Khan, Shumaila Manzoor, Muhammad Abubakar, Rokayya Sami, Saif A. Alharthy, Roua S. Baty, Ibrahim Jafri, Nouf H. Alsubhi, Sameer H. Qari & Ramla Shahid. (2022) Estrogen Induces c-myc Transcription by Binding to Upstream ERE Element in Promoter. Applied Sciences 12:14, pages 6853.
Crossref
Crossref
Marit Valla, Elise Klæstad, Borgny Ytterhus & Anna M. Bofin. (2022) CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis. Journal of Mammary Gland Biology and Neoplasia 27:1, pages 67-77.
Crossref
Crossref
Kate M. Moore, Vera Cerqueira, Kenneth G. MacLeod, Peter Mullen, Richard L. Hayward, Simon Green, David J. Harrison, David A. Cameron & Simon P. Langdon. (2022) Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model. Exploration of Targeted Anti-tumor Therapy, pages 97-116.
Crossref
Crossref
Maxwell R. Lloyd, Seth A. Wander, Erika Hamilton, Pedram Razavi & Aditya Bardia. (2022) Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role. Therapeutic Advances in Medical Oncology 14, pages 175883592211136.
Crossref
Crossref
Noha M. Bakr, Magda Sayed Mahmoud, Reem Nabil, Hussein Boushnak & Menha Swellam. (2021) Impact of circulating miRNA-373 on breast cancer diagnosis through targeting VEGF and cyclin D1 genes. Journal of Genetic Engineering and Biotechnology 19:1.
Crossref
Crossref
Manoj Kumar Dash, Namrata Joshi, D.N.S Gautam, Remya Jayakumar & Y.B. Tripathi. (2021) Ayurvedic supportive therapy in the management of breast cancer. Journal of Herbal Medicine 29, pages 100490.
Crossref
Crossref
Aaron R. Waddell, Haojie Huang & Daiqing Liao. (2021) CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers. Cancers 13:12, pages 2872.
Crossref
Crossref
Aaron Waddell, Iqbal Mahmud, Haocheng Ding, Zhiguang Huo & Daiqing Liao. (2021) Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer. Cancers 13:11, pages 2799.
Crossref
Crossref
Chad Liu, Yumi Konagaya, Mingyu Chung, Leighton H. Daigh, Yilin Fan, Hee Won Yang, Kenta Terai, Michiyuki Matsuda & Tobias Meyer. (2020) Altered G1 signaling order and commitment point in cells proliferating without CDK4/6 activity. Nature Communications 11:1.
Crossref
Crossref
Christine Lee, Kristine J. Fernandez, Sarah Alexandrou, C. Marcelo Sergio, Niantao Deng, Samuel Rogers, Andrew Burgess & C. Elizabeth Caldon. (2020) Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer. Cancers 12:8, pages 2268.
Crossref
Crossref
Ariella B. Hanker, Dhivya R. Sudhan & Carlos L. Arteaga. (2020) Overcoming Endocrine Resistance in Breast Cancer. Cancer Cell 37:4, pages 496-513.
Crossref
Crossref
Chen Xu & Junhua Zheng. (2019) siRNA against TSG101 reduces proliferation and induces G0/G1 arrest in renal cell carcinoma – involvement of c-myc, cyclin E1, and CDK2. Cellular & Molecular Biology Letters 24:1.
Crossref
Crossref
Yue Zhao, Chenxi Zhao, Jin Lu, Jun Wu, Changhao Li, Zhiye Hu, Wei Tian, Liang Yang, Jin Xiang, Haibin Zhou, Zixin Deng, Jian Huang & Kui Hong. (2019) Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader. Pharmacological Research 146, pages 104294.
Crossref
Crossref
Xueli Tian, KangDong Liu, Xueyin Zu, Fayang Ma, Zhi Li, MeeHyun Lee, Hanyong Chen, Yan Li, Yuzhou Zhao, Fangfang Liu, Naomi Oi, Ann M. Bode, Zigang Dong & Dong Joon Kim. (2019) 3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2. Cancer Letters 448, pages 20-30.
Crossref
Crossref
Camila López, Rodrigo Aguilar, Gino Nardocci, Karina Cereceda, Karen Vander Stelt, Juan Carlos Slebe, Martin Montecino & Ilona I. Concha. (2018) Wnt/β‐catenin signaling enhances transcription of the CX43 gene in murine Sertoli cells. Journal of Cellular Biochemistry 120:4, pages 6753-6762.
Crossref
Crossref
Nisha Thakur, Suchitra Kumari & Ravi Mehrotra. (2018)
Association between
Cyclin D1
G870A (rs9344) polymorphism and cancer risk in Indian population: meta-analysis and trial sequential analysis
. Bioscience Reports 38:6.
Crossref
Crossref
Rui Lopes, Gozde Korkmaz, Sonia Aristin Revilla, Romy van Vliet, Remco Nagel, Lars Custers, Yongsoo Kim, Pieter C. van Breugel, Wilbert Zwart, Behzad Moumbeini, Zohar Manber, Ran Elkon & Reuven Agami. (2018) CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells. Cancer Letters 436, pages 87-95.
Crossref
Crossref
Angela B. Ortiz, Diego Garcia, Yolanda Vicente, Magda Palka, Carmen Bellas & Paloma Martin. (2017) Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma. PLOS ONE 12:11, pages e0188068.
Crossref
Crossref
Yassi Fallah, Janetta Brundage, Paul Allegakoen & Ayesha N. Shajahan-Haq. (2017) MYC-Driven Pathways in Breast Cancer Subtypes. Biomolecules 7:4, pages 53.
Crossref
Crossref
Zahra Soleimani, Davood Kheirkhah, Mohammad Reza Sharif, Alireza Sharif, Mohammad Karimian & Younes Aftabi. (2016) Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis. Pathology & Oncology Research 23:3, pages 621-631.
Crossref
Crossref
Per Hydbring, Alina Castell & Lars-Gunnar Larsson. (2017) MYC Modulation around the CDK2/p27/SKP2 Axis. Genes 8:7, pages 174.
Crossref
Crossref
Woosung Chung, Hye Hyeon Eum, Hae-Ock Lee, Kyung-Min Lee, Han-Byoel Lee, Kyu-Tae Kim, Han Suk Ryu, Sangmin Kim, Jeong Eon Lee, Yeon Hee Park, Zhengyan Kan, Wonshik Han & Woong-Yang Park. (2017) Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nature Communications 8:1.
Crossref
Crossref
Erik S. Knudsen & Agnieszka K. Witkiewicz. (2017) The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies. Trends in Cancer 3:1, pages 39-55.
Crossref
Crossref
Xiao-Lin Wang, Wei-Ping Shi, Hong-Can Shi, Shi-Chun Lu, Kang Wang, Chao Sun, Jian-Sheng He, Wei-Guo Jin, Xiao-Xia Lv, Hui Zou & Yu-Sheng Shu. (2016) Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer. Oncotarget 7:49, pages 81527-81540.
Crossref
Crossref
Wanjun Lin, Jiajun Huang, Xiaolin Liao, Zhongwen Yuan, Senling Feng, Ying Xie & Wenzhe Ma. (2016) Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha. Pharmacological Research 111, pages 849-858.
Crossref
Crossref
Y. Qian, L. Xia, W. Shi, JJ. Sun & YQ. Sun. (2015) The effect of EGB on proliferation of gastric carcinoma SGC7901 cells. Clinical and Translational Oncology 18:5, pages 521-526.
Crossref
Crossref
Jian Kang, C Marcelo Sergio, Robert L Sutherland & Elizabeth A Musgrove. (2014) Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells. BMC Cancer 14:1.
Crossref
Crossref
J. M. Dixon. (2014) Endocrine Resistance in Breast Cancer. New Journal of Science 2014, pages 1-27.
Crossref
Crossref
Julia K. Blackmore, Sudipan Karmakar, Guowei Gu, Vaishali Chaubal, Liguo Wang, Wei Li & Carolyn L. Smith. (2014) The SMRT Coregulator Enhances Growth of Estrogen Receptor-α-Positive Breast Cancer Cells by Promotion of Cell Cycle Progression and Inhibition of Apoptosis. Endocrinology 155:9, pages 3251-3261.
Crossref
Crossref
Anna Maria Wróbel & Ewa Łucja Gregoraszczuk. (2014) Differential effect of methyl-, butyl- and propylparaben and 17β-estradiol on selected cell cycle and apoptosis gene and protein expression in MCF-7 breast cancer cells and MCF-10A non-malignant cells. Journal of Applied Toxicology 34:9, pages 1041-1050.
Crossref
Crossref
H. Zhang, X. Zhang, S. Ji, C. Hao, Y. Mu, J. Sun & J. Hao. (2014) Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1. Carcinogenesis 35:8, pages 1863-1871.
Crossref
Crossref
Erick Riquelme, Milind B. Suraokar, Jaime Rodriguez, Barbara Mino, Heather Y. Lin, David C. Rice, Anne Tsao & Ignacio I. Wistuba. (2014) Frequent Coamplification and Cooperation between C-MYC and PVT1 Oncogenes Promote Malignant Pleural Mesothelioma. Journal of Thoracic Oncology 9:7, pages 998-1007.
Crossref
Crossref
Agnieszka K Witkiewicz & Erik S Knudsen. (2014) Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions. Breast Cancer Research 16:2.
Crossref
Crossref
Mustafa Mir, Anna Bergamaschi, Benita S. Katzenellenbogen & Gabriel Popescu. (2014) Highly Sensitive Quantitative Imaging for Monitoring Single Cancer Cell Growth Kinetics and Drug Response. PLoS ONE 9:2, pages e89000.
Crossref
Crossref
Jaesik ChungHany NohKwang Hwa ParkEunhee ChoiAiri Han. (2014) Longer Survival in Patients with Breast Cancer with Cyclin D1 Over-Expression after Tumor Recurrence: Longer, but Occupied with Disease. Journal of Breast Cancer 17:1, pages 47.
Crossref
Crossref
F. E. Vera-Badillo, A. J. Templeton, P. de Gouveia, I. Diaz-Padilla, P. L. Bedard, M. Al-Mubarak, B. Seruga, I. F. Tannock, A. Ocana & E. Amir. (2013) Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis. JNCI Journal of the National Cancer Institute 106:1, pages djt319-djt319.
Crossref
Crossref
Kongming Wu, Zhaoming Li, Shaoxin Cai, Lifeng Tian, Ke Chen, Jing Wang, Junbo Hu, Ye Sun, Xue Li, Adam Ertel & Richard G. Pestell. (2013) EYA1 Phosphatase Function Is Essential to Drive Breast Cancer Cell Proliferation through Cyclin D1. Cancer Research 73:14, pages 4488-4499.
Crossref
Crossref
Paul M. Wilkerson & Jorge S. Reis-Filho. (2013) the 11q13-q14 amplicon: Clinicopathological correlations and potential drivers. Genes, Chromosomes and Cancer 52:4, pages 333-355.
Crossref
Crossref
David Ian Quinn & Gregory P. Swanson. 2013. Biomarkers in Oncology. Biomarkers in Oncology
189
247
.
Anne-Marie Gaben, Michèle Sabbah, Gérard Redeuilh, Monique Bedin & Jan Mester. (2012) Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells. BMC Cancer 12:1.
Crossref
Crossref
Noha Ezzat & Nesreen Hafez. (2012) The validity of immunocytochemical expression of cyclin D1 in fine needle aspiration cytology of breast carcinoma. Journal of the Egyptian National Cancer Institute 24:3, pages 145-150.
Crossref
Crossref
Fathima R. Kona, Karri Stark, Luke Bisoski, Daniela Buac, Qiuzhi Cui & Q. Ping Dou. (2012) Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor. Breast Cancer Research and Treatment 135:2, pages 495-503.
Crossref
Crossref
Nobuhiro Ijichi, Takashi Shigekawa, Kazuhiro Ikeda, Kuniko Horie-Inoue, Chikako Shimizu, Shigehira Saji, Kenjiro Aogi, Hitoshi Tsuda, Akihiko Osaki, Toshiaki Saeki & Satoshi Inoue. (2012) Association of Double-Positive FOXA1 and FOXP1 Immunoreactivities with Favorable Prognosis of Tamoxifen-Treated Breast Cancer Patients. Hormones and Cancer 3:4, pages 147-159.
Crossref
Crossref
C. Elizabeth Caldon, C. Marcelo Sergio, Jian Kang, Anita Muthukaruppan, Marijke N. Boersma, Andrew Stone, Jane Barraclough, Christine S. Lee, Michael A. Black, Lance D. Miller, Julia M. Gee, Rob I. Nicholson, Robert L. Sutherland, Cristin G. Print & Elizabeth A. Musgrove. (2012) Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells. Molecular Cancer Therapeutics 11:7, pages 1488-1499.
Crossref
Crossref
Kelly A. HolmesAntoni HurtadoGordon D. BrownRosalind LaunchburyCaryn S. Ross-InnesJames Hadfield, Duncan T. Odom & Jason S. Carroll. (2011) Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells. Proceedings of the National Academy of Sciences 109:8, pages 2748-2753.
Crossref
Crossref
Theodoros N. Sergentanis & Konstantinos P. Economopoulos. (2010) Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls. Molecular Biology Reports 38:8, pages 4955-4963.
Crossref
Crossref
Yoonseo Kim, Hyungjin Kim, Sung-Wuk Jang & Jesang Ko. (2011) The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells. Biochemical and Biophysical Research Communications 414:1, pages 199-204.
Crossref
Crossref
Todd W. Miller, Justin M. Balko, Zara Ghazoui, Anita Dunbier, Helen Anderson, Mitch Dowsett, Ana M. González-Angulo, Gordon B. Mills, William R. Miller, Huiyun Wu, Yu Shyr & Carlos L. Arteaga. (2011) A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance. Clinical Cancer Research 17:7, pages 2024-2034.
Crossref
Crossref
Simak AliLaki BuluwelaR. Charles Coombes. (2011) Antiestrogens and Their Therapeutic Applications in Breast Cancer and Other Diseases. Annual Review of Medicine 62:1, pages 217-232.
Crossref
Crossref
Ying-Wei Li, Guo-Yuan Zhu, Xiao-Ling Shen, Jian-Hong Chu, Zhi-Ling Yu & Wang-Fun Fong. (2011) Furanodienone inhibits cell proliferation and survival by suppressing ERα signaling in human breast cancer MCF-7 cells. Journal of Cellular Biochemistry 112:1, pages 217-224.
Crossref
Crossref
Cécilia Szatkowski, Jan B Parys, Halima Ouadid-Ahidouch & Fabrice Matifat. (2010) Inositol 1,4,5-trisphosphate-induced Ca2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth. Molecular Cancer 9:1.
Crossref
Crossref
Binoj C. Nair, Sujit S. Nair, Dimple Chakravarty, Rambabu Challa, Bramanandam Manavathi, P. Renee Yew, Rakesh Kumar, Rajeshwar Rao Tekmal & Ratna K. Vadlamudi. (2010) Cyclin-Dependent Kinase–Mediated Phosphorylation Plays a Critical Role in the Oncogenic Functions of PELP1. Cancer Research 70:18, pages 7166-7175.
Crossref
Crossref
Carla Cavaliere, Sara Corvigno, Mario Galgani, Gennaro Limite, Agostina Nardone & Bianca Maria Veneziani. (2010) Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells. Cancer Science 101:7, pages 1661-1669.
Crossref
Crossref
Mathieu Dalvai & Kerstin Bystricky. (2010) Cell Cycle and Anti-Estrogen Effects Synergize to Regulate Cell Proliferation and ER Target Gene Expression. PLoS ONE 5:6, pages e11011.
Crossref
Crossref
Huaqing Liu, Juan Du, Chunyan Hu, Hong Qi, Xinru Wang, Shoulin Wang, Qizhan Liu & Zhong Li. (2010) Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-α-mediated transcription in MCF-7 breast cancer cells. The Journal of Nutritional Biochemistry 21:5, pages 390-396.
Crossref
Crossref
A. Villavicencio, G. Aguilar, G. Argüello, C. Dünner, F. Gabler, E. Soto, F. Gaete, P. Peñaloza, M. Celis & C. Rojas. (2010) The effect of overweight and obesity on proliferation and activation of AKT and ERK in human endometria. Gynecologic Oncology 117:1, pages 96-102.
Crossref
Crossref
Shayne Cox GadSean Ekins, Andrej Bugrim, Yuri Nikolsky & Tatiana Nikolskaya. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Caryn S. Ross-Innes, Rory Stark, Kelly A. Holmes, Dominic Schmidt, Christiana Spyrou, Roslin Russell, Charlie E. Massie, Sarah L. Vowler, Matthew Eldridge & Jason S. Carroll. (2010) Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancer. Genes & Development 24:2, pages 171-182.
Crossref
Crossref
Pankaj G. Roy, Norman Pratt, Colin A. Purdie, Lee Baker, Alison Ashfield, Phil Quinlan & Alastair M. Thompson. (2010) High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer. International Journal of Cancer, pages NA-NA.
Crossref
Crossref
Huining Tan, Yili Zhong & Zhongzong Pan. (2009) Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines. BMC Cancer 9:1.
Crossref
Crossref
Yong Zhang, Donald Y.M. Leung, Steven K. Nordeen & Elena Goleva. (2009) Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation. Journal of Biological Chemistry 284:36, pages 24542-24552.
Crossref
Crossref
Elizabeth A. Musgrove & Robert L. Sutherland. (2009) Biological determinants of endocrine resistance in breast cancer. Nature Reviews Cancer 9:9, pages 631-643.
Crossref
Crossref
M. Chehani Alles, Margaret Gardiner-Garden, David J. Nott, Yixin Wang, John A. Foekens, Robert L. Sutherland, Elizabeth A. Musgrove & Christopher J. Ormandy. (2009) Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup. PLoS ONE 4:3, pages e4710.
Crossref
Crossref
D. Amendola, M. De Salvo, R. Marchese, C. Verga Falzacappa, A. Stigliano, E. Carico, E. Brunetti, M. Moscarini & B. Bucci. (2009)
Myc down-regulation affects cyclin D1/cdk4 activity and induces apoptosis
via
Smac/Diablo pathway in an astrocytoma cell line
. Cell Proliferation 42:1, pages 94-109.
Crossref
Crossref
Sai-Wen Tang, Wen-Hsin Chang, Yih-Ching Su, Yu-Chi Chen, Yen-Han Lai, Pei-Tzu Wu, Chyong-Ing Hsu, Wei-Chou Lin, Ming-Kuen Lai & Jung-Yaw Lin. (2009) MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Cancer Letters 273:1, pages 35-43.
Crossref
Crossref
Colin K. W. Watts, Owen W. J. Prall, Jason S. Carroll, Nicholas R. C. Wilcken, Eileen M. Rogan, Elizabeth A. Musgrove & Robert L. Sutherland. 2009. Hormone Therapy in Breast and Prostate Cancer. Hormone Therapy in Breast and Prostate Cancer
17
45
.
Kelly A. Holmes, Jun S. Song, Xiaole S. Liu, Myles Brown & Jason S. Carroll. (2008) Nkx3-1 and LEF-1 Function as Transcriptional Inhibitors of Estrogen Receptor Activity. Cancer Research 68:18, pages 7380-7385.
Crossref
Crossref
Elizabeth A. Musgrove, C. Marcelo Sergio, Sherene Loi, Claire K. Inman, Luke R. Anderson, M. Chehani Alles, Mark Pinese, C. Elizabeth Caldon, Judith Schütte, Margaret Gardiner-Garden, Christopher J. Ormandy, Grant McArthur, Alison J. Butt & Robert L. Sutherland. (2008) Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer. PLoS ONE 3:8, pages e2987.
Crossref
Crossref
Somaia Elsheikh, Andrew R. Green, Mohammed A. Aleskandarany, Matthew Grainge, Claire E. Paish, Maryou B. K. Lambros, Jorge S. Reis-Filho & Ian O. Ellis. (2007) CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome. Breast Cancer Research and Treatment 109:2, pages 325-335.
Crossref
Crossref
Alison J Butt, C Marcelo Sergio, Claire K Inman, Luke R Anderson, Catriona M McNeil, Amanda J Russell, Marco Nousch, Thomas Preiss, Andrew V Biankin, Robert L Sutherland & Elizabeth A Musgrove. (2008) The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome. Breast Cancer Research 10:2.
Crossref
Crossref
Sara C. Dietz & Jason S. Carroll. (2008) Interrogating the genome to understand oestrogen-receptor-mediated transcription. Expert Reviews in Molecular Medicine 10.
Crossref
Crossref
Yuki Ishii, Samuel Waxman & Doris Germain. (2008) Tamoxifen Stimulates the Growth of Cyclin D1–Overexpressing Breast Cancer Cells by Promoting the Activation of Signal Transducer and Activator of Transcription 3. Cancer Research 68:3, pages 852-860.
Crossref
Crossref
Robert L. Sutherland, C. Marcelo Sergio, CatrionaM. McNeil, Luke R. Anderson, Claire K. Inman, Alison J. Butt & Elizabeth A. Musgrove. 2008. Hormonal Control of Cell Cycle. Hormonal Control of Cell Cycle
123
138
.
Alison J. Butt, C. Elizabeth Caldon, Catriona M. McNeil, Alexander Swarbrick, Elizabeth A. Musgrove & Robert L. Sutherland. 2008. Innovative Endocrinology of Cancer. Innovative Endocrinology of Cancer
189
205
.
Elizabeth A. Musgrove, C. Marcelo Sergio, Luke R. Anderson, Claire K. Inman, Catriona M. McNeil, M. Chehani Alles, Margaret Gardiner-Garden, Christopher J. Ormandy, Alison J. Butt & Robert L. Sutherland. 2008. Hormonal Carcinogenesis V. Hormonal Carcinogenesis V
445
451
.
Hemant Varma, Andrew J. Skildum & Susan E. Conrad. (2007) Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells. PLoS ONE 2:12, pages e1256.
Crossref
Crossref
David G. DeNardo, Valerie L. Cuba, HeeTae Kim, Kendall Wu, Adrian V. Lee & Powel H. Brown. (2007) Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth. Molecular and Cellular Endocrinology 277:1-2, pages 13-25.
Crossref
Crossref
Eileen M. McGowan, Amanda J. Russell, Viroj Boonyaratanakornkit, Darren N. Saunders, Gillian M. Lehrbach, C. Marcelo Sergio, Elizabeth A. Musgrove, Dean P. Edwards & Robert L. Sutherland. (2007) Progestins Reinitiate Cell Cycle Progression in Antiestrogen-Arrested Breast Cancer Cells through the B-Isoform of Progesterone Receptor. Cancer Research 67:18, pages 8942-8951.
Crossref
Crossref
Romaine Fernando, James S. Foster, Amber Bible, Anders Ström, Richard G. Pestell, Mahadev Rao, Arnold Saxton, Seung Joon Baek, Kiyoshi Yamaguchi, Robert Donnell, Maria Cekanova & Jay Wimalasena. (2007) Breast Cancer Cell Proliferation Is Inhibited by BAD. Journal of Biological Chemistry 282:39, pages 28864-28873.
Crossref
Crossref
Kelly A. Green & Jason S. Carroll. (2007) Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nature Reviews Cancer 7:9, pages 713-722.
Crossref
Crossref
Sallyann L. O'Brien, Ailís Fagan, Edward J.P. Fox, Robert C. Millikan, Aedín C. Culhane, Donal J. Brennan, Amanda H. McCann, Shauna Hegarty, Siobhan Moyna, Michael J. Duffy, Desmond G. Higgins, Karin Jirström, Göran Landberg & William M. Gallagher. (2007) CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer. International Journal of Cancer 120:7, pages 1434-1443.
Crossref
Crossref
Maricarmen D. Planas-Silva, Richard D. Bruggeman, Ronald T. Grenko & J.S. Smith. (2007) Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer. Experimental and Molecular Pathology 82:1, pages 85-90.
Crossref
Crossref
Robin L. Kilker & Maricarmen D. Planas-Silva. (2006) Cyclin D1 Is Necessary for Tamoxifen-Induced Cell Cycle Progression in Human Breast Cancer Cells. Cancer Research 66:23, pages 11478-11484.
Crossref
Crossref
Catriona M. McNeil, C. Marcelo Sergio, Luke R. Anderson, Claire K. Inman, Sarah A. Eggleton, Niamh C. Murphy, Ewan K.A. Millar, Paul Crea, James G. Kench, M. Chehani Alles, Margaret Gardiner-Garden, Christopher J. Ormandy, Alison J. Butt, Susan M. Henshall, Elizabeth A. Musgrove & Robert L. Sutherland. (2006) c-Myc overexpression and endocrine resistance in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 102:1-5, pages 147-155.
Crossref
Crossref
Pankaj G. Roy & Alastair M. Thompson. (2006) Cyclin D1 and breast cancer. The Breast 15:6, pages 718-727.
Crossref
Crossref
Jérôme Eeckhoute, Jason S. Carroll, Timothy R. Geistlinger, Maria I. Torres-Arzayus & Myles Brown. (2006) A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes & Development 20:18, pages 2513-2526.
Crossref
Crossref
Jason S. Carroll & Myles Brown. (2006) Estrogen Receptor Target Gene: An Evolving Concept. Molecular Endocrinology 20:8, pages 1707-1714.
Crossref
Crossref
Amit Nahum, Lior Zeller, Michael Danilenko, Owen W. J. Prall, Colin K. W. Watts, Robert L. Sutherland, Joseph Levy & Yoav Sharoni. (2006) Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. European Journal of Nutrition 45:5, pages 275-282.
Crossref
Crossref
Marie-Noelle Dieudonne, Marianne Bussiere, Esther Dos Santos, Marie-Christine Leneveu, Yves Giudicelli & René Pecquery. (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochemical and Biophysical Research Communications 345:1, pages 271-279.
Crossref
Crossref
Jie Liu, Yaxiong Xie, Danica M.K. Ducharme, Jun Shen, Bhalchandra A. Diwan, B. Alex Merrick, Sherry F. Grissom, Charles J. Tucker, Richard S. Paules, Raymond Tennant & Michael P. Waalkes. (2006)
Global Gene Expression Associated with Hepatocarcinogenesis in Adult Male Mice Induced by
in Utero
Arsenic Exposure
. Environmental Health Perspectives 114:3, pages 404-411.
Crossref
Crossref
Harold Kim, Mike Laing & William Muller. (2005) c-Src-null mice exhibit defects in normal mammary gland development and ERα signaling. Oncogene 24:36, pages 5629-5636.
Crossref
Crossref
Zara K. Melkoumian, Xu Peng, Boyi Gan, Xiaoyang Wu & Jun-Lin Guan. (2005) Mechanism of Cell Cycle Regulation by FIP200 in Human Breast Cancer Cells. Cancer Research 65:15, pages 6676-6684.
Crossref
Crossref
Oswaldo G. Rodriguez-Mora, Michelle M. LaHair, James A. McCubrey & Richard A. Franklin. (2005) Calcium/Calmodulin-Dependent Kinase I and Calcium/Calmodulin-Dependent Kinase Kinase Participate in the Control of Cell Cycle Progression in MCF-7 Human Breast Cancer Cells. Cancer Research 65:12, pages 5408-5416.
Crossref
Crossref
Erika Krasnickas Keeton & Myles Brown. (2005) Cell Cycle Progression Stimulated by Tamoxifen-Bound Estrogen Receptor-α and Promoter-Specific Effects in Breast Cancer Cells Deficient in N-CoR and SMRT. Molecular Endocrinology 19:6, pages 1543-1554.
Crossref
Crossref
Jie Sun, Lixin Xie, Yao Wang & Ting Liu. (2005) Inhibition of human lens epithelial B-3 cell proliferation by adenovirus-mediated transfer of antisense c-myc construct. Graefe's Archive for Clinical and Experimental Ophthalmology 243:6, pages 601-606.
Crossref
Crossref
Shibani Mukherjee & Susan E. Conrad. (2005) c-Myc Suppresses p21WAF1/CIP1 Expression during Estrogen Signaling and Antiestrogen Resistance in Human Breast Cancer Cells. Journal of Biological Chemistry 280:18, pages 17617-17625.
Crossref
Crossref
Soo Ok Lee, Nagalakshmi Nadiminty, Xiu Xian Wu, Wei Lou, Yan Dong, Clement Ip, Sergio A. Onate & Allen C. Gao. (2005) Selenium Disrupts Estrogen Signaling by Altering Estrogen Receptor Expression and Ligand Binding in Human Breast Cancer Cells. Cancer Research 65:8, pages 3487-3492.
Crossref
Crossref
Jui-Wen Huang, Chung-Wai Shiau, Ya-Ting Yang, Samuel K. Kulp, Kuen-Feng Chen, Robert W. Brueggemeier, Charles L. Shapiro & Ching-Shih Chen. (2005) Peroxisome Proliferator-Activated Receptor γ-Independent Ablation of Cyclin D1 by Thiazolidinediones and Their Derivatives in Breast Cancer Cells. Molecular Pharmacology 67:4, pages 1342-1348.
Crossref
Crossref
Josephine White, Elaine Stead, Renate Faast, Simon Conn, Peter Cartwright & Stephen Dalton. (2005) Developmental Activation of the Rb–E2F Pathway and Establishment of Cell Cycle-regulated Cyclin-dependent Kinase Activity during Embryonic Stem Cell Differentiation. Molecular Biology of the Cell 16:4, pages 2018-2027.
Crossref
Crossref
David I. Quinn, Susan M. Henshall & Robert L. Sutherland. (2005) Molecular markers of prostate cancer outcome. European Journal of Cancer 41:6, pages 858-887.
Crossref
Crossref
Rania Kairouz, Jayamala Parmar, Ruth J. Lyons, Alexander Swarbrick, Elizabeth A. Musgrove & Roger J. Daly. (2005) Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells. Journal of Cellular Physiology 203:1, pages 85-93.
Crossref
Crossref
Alexander Swarbrick, Mia C Åkerfeldt, Christine S L Lee, C Marcelo Sergio, C Elizabeth Caldon, Lisa-Jane K Hunter, Robert L Sutherland & Elizabeth A Musgrove. (2004) Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix–loop–helix protein Id1. Oncogene 24:3, pages 381-389.
Crossref
Crossref
Amanda Mawson, Angela Lai, Jason S. Carroll, C. Marcelo Sergio, Christopher J. Mitchell & Boris Sarcevic. (2005) Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Molecular and Cellular Endocrinology 229:1-2, pages 161-173.
Crossref
Crossref
Anne-Marie Gaben, Cécile Saucier, Monique Bedin, Gérard Redeuilh & Jan Mester. (2004) Mitogenic Activity of Estrogens in Human Breast Cancer Cells Does Not Rely on Direct Induction of Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase or Phosphatidylinositol 3-Kinase. Molecular Endocrinology 18:11, pages 2700-2713.
Crossref
Crossref
Robin L. Kilker, Michael W. Hartl, Tina M. Rutherford & Maricarmen D. Planas-Silva. (2004) Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 92:1-2, pages 63-71.
Crossref
Crossref
Seetharaman Balasenthil, Christopher J. Barnes, Suresh K. Rayala & Rakesh Kumar. (2004) Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. FEBS Letters 567:2-3, pages 243-247.
Crossref
Crossref
Anders Ström, Johan Hartman, James S. Foster, Silke Kietz, Jay Wimalasena & Jan-Åke Gustafsson. (2004) Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proceedings of the National Academy of Sciences 101:6, pages 1566-1571.
Crossref
Crossref
Seetharaman Balasenthil, Aysegul A. Sahin, Christopher J. Barnes, Rui-An Wang, Richard G. Pestell, Ratna K. Vadlamudi & Rakesh Kumar. (2004) p21-activated Kinase-1 Signaling Mediates Cyclin D1 Expression in Mammary Epithelial and Cancer Cells. Journal of Biological Chemistry 279:2, pages 1422-1428.
Crossref
Crossref
Steven S Chua, Zhiqing Ma, Elly Ngan & Sophia Y Tsai. 2004. Nuclear Receptor Coregulators. Nuclear Receptor Coregulators
231
256
.
Lakjaya Buluwela, Demetra Constantinidou, Joanna Pike & Simak Ali. 2004. Molecular Targeting and Signal Transduction. Molecular Targeting and Signal Transduction
271
292
.
Robert B Clarke. (2003) Steroid receptors and proliferation in the human breast. Steroids 68:10-13, pages 789-794.
Crossref
Crossref
AN Scholten, CL Creutzberg, LJCM van den Broek, EM Noordijk & VTHBM Smit. (2003) Nuclear ?-catenin is a molecular feature of type I endometrial carcinoma. The Journal of Pathology 201:3, pages 460-465.
Crossref
Crossref
James S. Foster, Romaine I. Fernando, Noriko Ishida, Keiichi I. Nakayama & Jay Wimalasena. (2003) Estrogens Down-regulate p27 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK Pathway. Journal of Biological Chemistry 278:42, pages 41355-41366.
Crossref
Crossref
Sophie F. Doisneau-Sixou, Philippe Cestac, Jean-Charles Faye, Gilles Favre & Robert L. Sutherland. (2003) Additive effects of tamoxifen and the farnesyl transferase inhibitor FTI-277 on inhibition of MCF-7 breast cancer cell-cycle progression. International Journal of Cancer 106:5, pages 789-798.
Crossref
Crossref
Wei Yue, Ji-Ping Wang, Mark R. Conaway, Yuebai Li & Richard J. Santen. (2003) Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways. The Journal of Steroid Biochemistry and Molecular Biology 86:3-5, pages 265-274.
Crossref
Crossref
Pierre Rudolph, Heidi Kühling, Per Alm, Mårten Fernö, Bo Baldetorp, Håkan Olsson & Reza Parwaresch. (2003) Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer. International Journal of Cancer 105:5, pages 674-680.
Crossref
Crossref
Constantine Dimitrakakis, Jian Zhou, Jie Wang, Alain Belanger, Fernand LaBrie, Clara Cheng, Douglas Powell & Carolyn Bondy. (2003) A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause 10:4, pages 292-298.
Crossref
Crossref
Seetharaman Balasenthil & Ratna K. Vadlamudi. (2003) Functional Interactions between the Estrogen Receptor Coactivator PELP1/MNAR and Retinoblastoma Protein. Journal of Biological Chemistry 278:24, pages 22119-22127.
Crossref
Crossref
Jean-Philippe Coppé, Andrew P Smith & Pierre-Yves Desprez. (2003) Id proteins in epithelial cells. Experimental Cell Research 285:1, pages 131-145.
Crossref
Crossref
Zaroui K. Melkoumian, Anna R. Martirosyan & Jeannine S. Strobl. (2002) Myc protein is differentially sensitive to quinidine in tumorversus immortalized breast epithelial cell lines. International Journal of Cancer 102:1, pages 60-69.
Crossref
Crossref
Wei Yue, Ji-Ping Wang, Mark Conaway, Shigeru Masamura, Yuebai Li & Richard J. Santen. (2002) Activation of the MAPK Pathway Enhances Sensitivity of MCF-7 Breast Cancer Cells to the Mitogenic Effect of Estradiol. Endocrinology 143:9, pages 3221-3229.
Crossref
Crossref
Roger J Daly, Haihua Gu, Jayamala Parmar, Suzann Malaney, Ruth J Lyons, Rania Kairouz, Darren R Head, Susan M Henshall, Benjamin G Neel & Robert L Sutherland. (2002) The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene 21:33, pages 5175-5181.
Crossref
Crossref
Robert Clarke, Anthony Howell & Elizabeth Anderson. 2002. Breast Cancer. Breast Cancer
73
91
.
Julia Gee & Robert Nicholson. 2002. Breast Cancer. Breast Cancer
301
342
.
Meng-Min Liu, Chris Albanese, Carol M. Anderson, Kristin Hilty, Paul Webb, Rosalie M. Uht, Richard H. PriceJr.Jr., Richard G. Pestell & Peter J. Kushner. (2002) Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression. Journal of Biological Chemistry 277:27, pages 24353-24360.
Crossref
Crossref
Shamila Ahamed, James S. Foster, Antonin Bukovsky, J. Alan Diehl & Jay Wimalasena. (2002) Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells. Molecular Carcinogenesis 34:1, pages 45-58.
Crossref
Crossref
Marcello Venditti, Barbara Iwasiow, F. William Orr & Robert P.C. Shiu. (2002) C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells. International Journal of Cancer 99:1, pages 35-42.
Crossref
Crossref
Andrew J. Skildum, Shibani Mukherjee & Susan E. Conrad. (2002) The Cyclin-dependent Kinase Inhibitor p21WAF1/Cip1 Is an Antiestrogen-regulated Inhibitor of Cdk4 in Human Breast Cancer Cells. Journal of Biological Chemistry 277:7, pages 5145-5152.
Crossref
Crossref
Göran Landberg. 2002.
35
56
.
G. Prem Veer Reddy, Eugenia Cifuentes, Mani Menon & Evelyn R. Barrack. 2002. Steroid Hormones and Cell Cycle Regulation. Steroid Hormones and Cell Cycle Regulation
111
135
.
Jason S. Carroll, Owen W. J. Prall, Claudio M. Sergio, Eileen M. Rogan, Colin K. W. Watts, Elizabeth A. Musgrove & Robert L. Sutherland. 2002. Steroid Hormones and Cell Cycle Regulation. Steroid Hormones and Cell Cycle Regulation
57
71
.
Jane M. Turbov, George M. Twaddle, Xiaohe Yang, Naxin M. Liu & Satya Murthy. (2002) Effects of receptor tyrosine kinase inhibitor A47 on estrogen and growth factor-dependent breast cancer cell proliferation and apoptosis in vitro. Journal of Surgical Oncology 79:1, pages 17-29.
Crossref
Crossref
Elizabeth A. Musgrove, Lisa-Jane K. Hunter, Christine S.L. Lee, Alexander Swarbrick, Rina Hui & Robert L. Sutherland. (2001) Cyclin D1 Overexpression Induces Progestin Resistance in T-47D Breast Cancer Cells Despite p27Kip1 Association with Cyclin E-Cdk2. Journal of Biological Chemistry 276:50, pages 47675-47683.
Crossref
Crossref
Scott Wadler. (2001) Perspectives for cancer therapies with cdk2 inhibitors. Drug Resistance Updates 4:6, pages 347-367.
Crossref
Crossref
Anthony Howell, Sacha J Howell, Robert Clarke & Elizabeth Anderson. (2001) Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?. The Journal of Steroid Biochemistry and Molecular Biology 79:1-5, pages 227-237.
Crossref
Crossref
Jeffrey C.H. Donovan, Andrea Milic & Joyce M. Slingerland. (2001) Constitutive MEK/MAPK Activation Leads to p27Kip1Deregulation and Antiestrogen Resistance in Human Breast Cancer Cells. Journal of Biological Chemistry 276:44, pages 40888-40895.
Crossref
Crossref
Owen W.J. Prall, Jason S. Carroll & Robert L. Sutherland. (2001) A Low Abundance Pool of Nascent p21WAF1/Cip1 Is Targeted by Estrogen to Activate Cyclin E·Cdk2. Journal of Biological Chemistry 276:48, pages 45433-45442.
Crossref
Crossref
Jaana K Rummukainen, Tiina Salminen, Johan Lundin, Soili Kytölä, Heikki Joensuu & Jorma J Isola. (2001) Amplification of c-myc by Fluorescence In Situ Hybridization in a Population-Based Breast Cancer Tissue Array. Modern Pathology 14:10, pages 1030-1035.
Crossref
Crossref
James S. Foster, Donald C. Henley, Shamila Ahamed & Jay Wimalasena. (2001) Estrogens and cell-cycle regulation in breast cancer. Trends in Endocrinology & Metabolism 12:7, pages 320-327.
Crossref
Crossref
Tae Jung Jang, Jae Hum Park, Mee Yon Cho & Jung Ran Kim. (2001) Chemically induced rat mammary tumor treated with tamoxifen showed decreased expression of cyclin D1, cyclin E, and p21Cip1. Cancer Letters 170:2, pages 109-116.
Crossref
Crossref
Gudrun Urban, Teresa Golden, Ileana V. Aragon, Jonathan G. Scammell, Nicholas M. Dean & Richard E. Honkanen. (2001) Identification of an Estrogen-inducible Phosphatase (PP5) That Converts MCF-7 Human Breast Carcinoma Cells into an Estrogen-independent Phenotype when Expressed Constitutively. Journal of Biological Chemistry 276:29, pages 27638-27646.
Crossref
Crossref
Angela Lai, Boris Sarcevic, Owen W.J. Prall & Robert L. Sutherland. (2001) Insulin/Insulin-like Growth Factor-I and Estrogen Cooperate to Stimulate Cyclin E-Cdk2 Activation and Cell Cycle Progression in MCF-7 Breast Cancer Cells through Differential Regulation of Cyclin E and p21WAF1/Cip1. Journal of Biological Chemistry 276:28, pages 25823-25833.
Crossref
Crossref
Yu-Jin Jung, Kee-Ho Lee, Dong-Wook Choi, Chul Ju Han, Sook Hyang Jeong, Keun-Cheol Kim, Jong-Won Oh, Taek-Kyu Park & Chang-Min Kim. (2001) Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma. Cancer Letters 168:1, pages 57-63.
Crossref
Crossref
Kyeongmee Park, Sehwan Han, Hong-Yong Kim & Ilhyang Ko. (2001) Cytologic evaluation of cyclin D1 expression in primary breast carcinoma. Cancer 93:3, pages 211-215.
Crossref
Crossref
Domenico Germano, Carmen Pacilio, Massimo Cancemi, Luigi Cicatiello, Lucia Altucci, Valeria Belsito Petrizzi, Carmine Sperandio, Salvatore Salzano, Rob J.A.M. Michalides, Yoichi Taya, Francesco Bresciani & Alessandro Weisz. (2001) Inhibition of Human Breast Cancer Cell Growth by Blockade of the Mevalonate-Protein Prenylation Pathway is not Prevented by Overexpression of Cyclin D1. Breast Cancer Research and Treatment 67:1, pages 23-33.
Crossref
Crossref
Diana Manole, Beatrice Schildknecht, Bernadett Gosnell, Eric Adams & Michael Derwahl. (2001) Estrogen Promotes Growth of Human Thyroid Tumor Cells by Different Molecular Mechanisms1. The Journal of Clinical Endocrinology & Metabolism 86:3, pages 1072-1077.
Crossref
Crossref
Robert L Sutherland & Elizabeth A Musgrove. (2001) Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models. Breast Cancer Research 4:1.
Crossref
Crossref
Shamila Ahamed, James S. Foster, Antonin Bukovsky & Jay Wimalasena. (2001) Signal transduction through the ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell-cycle progression in MCF-7 cells. Molecular Carcinogenesis 30:2, pages 88-98.
Crossref
Crossref
Runqing Lu & Ginette Serrero. (2000) Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor). Proceedings of the National Academy of Sciences 98:1, pages 142-147.
Crossref
Crossref
Owen W. J. Prall, Eileen M. Rogan, Elizabeth A. Musgrove, Colin K. W. Watts & Robert L. Sutherland. 2001. Hormonal Carcinogenesis III. Hormonal Carcinogenesis III
220
227
.
Jason S. Carroll, Owen W.J. Prall, Elizabeth A. Musgrove & Robert L. Sutherland. (2000) A Pure Estrogen Antagonist Inhibits Cyclin E-Cdk2 Activity in MCF-7 Breast Cancer Cells and Induces Accumulation of p130-E2F4 Complexes Characteristic of Quiescence. Journal of Biological Chemistry 275:49, pages 38221-38229.
Crossref
Crossref
Peter W Schlosshauer, Edyta C Pirog, Ross L Levine & Lora Hedrick Ellenson. (2000) Mutational Analysis of the CTNNB1 and APC Genes in Uterine Endometrioid Carcinoma. Modern Pathology 13:10, pages 1066-1071.
Crossref
Crossref
Hemant Varma & Susan E Conrad. (2000) Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain. Oncogene 19:41, pages 4746-4753.
Crossref
Crossref
Alexander Pajic, Dimitry Spitkovsky, Barbara Christoph, Bettina Kempkes, Marino Schuhmacher, Martin S. Staege, Markus Brielmeier, Joachim Ellwart, Franz Kohlhuber, Georg W. Bornkamm, Axel Polack & Dirk Eick. (2000) Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. International Journal of Cancer 87:6, pages 787-793.
Crossref
Crossref
Sandrine Cariou, Jeffrey C. H. Donovan, W. M. Flanagan, Andrea Milic, Nandita Bhattacharya & Joyce M. Slingerland. (2000)
Down-regulation of p21
WAF1/CIP1
or p27
Kip1
abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells
. Proceedings of the National Academy of Sciences 97:16, pages 9042-9046.
Crossref
Crossref
Kay L. MedinaAndreas StrasserPaul W. Kincade. (2000) Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95:6, pages 2059-2067.
Crossref
Crossref
Dezhong J Liao, Geraldine Natarajan, Sandra L Deming, M Hunter Jamerson, Michael Johnson, Gloria Chepko & Robert B Dickson. (2000) Cell cycle basis for the onset and progression of c-Myc-induced, TGFα-enhanced mouse mammary gland carcinogenesis. Oncogene 19:10, pages 1307-1317.
Crossref
Crossref
Qun Zhou, Julia Wulfkuhle, Taoufik Ouatas, Paula Fukushima, Maryalice Stetler-Stevenson, Fred R. Miller & Patricia S. Steeg. (2000) Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity. Breast Cancer Research and Treatment 59:1, pages 27-39.
Crossref
Crossref
Richard G. PestellChris AlbaneseAnne T. ReutensJeffrey E. SegallRichard J. LeeAndrew Arnold. (1999) The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation*. Endocrine Reviews 20:4, pages 501-534.
Crossref
Crossref
Michael Shtutman, Jacob Zhurinsky, Inbal Simcha, Chris Albanese, Mark D’Amico, Richard Pestell & Avri Ben-Ze’ev. (1999) The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proceedings of the National Academy of Sciences 96:10, pages 5522-5527.
Crossref
Crossref